Cap.
10.29
Notice Regarding the Completion of Cash Capital Increase and Determination of Capital Increase Record Date for Year 2024.
Info
09.03
Seizing the overseas dressing market, AMS BioteQ obtains its first distribution contract in Japan.
Cap.
08.27
AMS BioteQ (TPE:6864) will conduct a rights issue of 40 million NT dollars, with the ex-rights date on September 12. The issue price is set at 28 NT dollars per share.
Info
08.27
The board of directors of AMS BioteQ (TPE:6864) approved the appointment of Deputy General Manager Zhang Yiwei.
Cap.
08.07
AMS BioteQ (TPE:6864) has resolved to issue 4 million new shares, with a tentative price of 28 NT dollars per share. Each thousand shares can subscribe for approximately 119.95 shares.
Info
07.18
Officially signed a distributor agreement with VITAHOUSE PHARAC PTY CO., LIMITED for the mainland region.
Pat.
07.11
SIPSIP Foam has obtained Class I medical device sales approval from the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan.
Info
04.24
The board of directors of AMS BioteQ has resolved to issue common shares by way of a private placement.
Info
04.24
Announcement of the Board Resolution of AMS BioteQ Regarding the Convening of the 113th Annual Shareholders' Meeting
Info
04.24
The decision of the AMS BioteQ Board of Directors to establish a branch office in Tokyo, Japan and appoint a representative for the branch office.
Info
04.17
AMS BioteQ was invited to exhibit at the inaugural Japan Pharmaceutical Exhibition.
Pat.
03.25
"Artificial Dressing and Its Application for Promoting Wound Healing" "patent approved by the United States Patent and Trademark Office."
Info
03.22
Signed a memorandum of understanding (MOU) on industry-academic collaboration with the School of Pharmacy, Kaohsiung Medical University, to enhance industry-academic exchanges.
Cap.
01.31
The capital increase case for the year 112, with a fund of 75 million NTD, has been fully subscribed, and the capital increase base date is set on 1st February.
Pat.
01.18
"Artificial Dressing and Its Application for Promoting Wound Healing" has successfully obtained approval for a new invention patent in Taiwan.
Pat.
01.11
SIPSIP™ Foam, the AMS BioteQ wound dressing, has successfully obtained FDA registration.